Investors and Media Relations
The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.
We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients.
| Infinity Pharmaceuticals (NASD: INFI) |
4:12 PM ET on May 8, 2008 |
| Last Price |
Change |
Open |
Day High |
52-Week High |
7.33 |
0.07  (0.96%) |
7.26 |
7.33 |
11.42 |
| Volume |
Previous Close |
Day Low |
52-Week Low |
| 8,900 |
7.26 |
6.95 |
5.00 |
Recent Events
May 5, 2008
Infinity Pharmaceuticals First Quarter 2008 Results
May 2, 2008
Morgan Stanley 2008 Global Healthcare Unplugged Conference
more »
Annual Report
Click here to view the 2007 Annual Report
Recent Releases
May 5, 2008
Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results
Apr 28, 2008
Infinity Announces Conference Call Discussing R&D Progress and First Quarter 2008 Results
more »
|
